Myelodysplastic following treatment of chronic lymphocytic leukemia (CLL) with 2-chlorodeoxyadenosine (2-CdA)

被引：0
|
作者：
SH Kroft
MS Tallman
JM Shaw
M Thangavelu
LA Peterson
机构：
来源：
Leukemia | 1997年 / 11卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：170 / 170
相关论文
共 50 条
  • [11] Successful treatment of prolymphocytic leukemia with splenic irradiation and 2-chlorodeoxyadenosine (2-CDA).
    Berrebi, A
    Shvidel, L
    Shtalrid, M
    Klepfish, A
    Sigler, E
    [J]. BLOOD, 1997, 90 (10) : 4122 - 4122
  • [12] 2-chlorodeoxyadenosine (2-CDA) in previously untreated chronic lymphocytic leukemia (CLL) - Preliminary analysis from the Australian leukemia study group trial.
    Mulligan, SP
    Eliadis, P
    Dale, B
    Bunce, I
    Bashford, J
    Page, F
    Matthews, J
    Bradstock, K
    [J]. BLOOD, 1995, 86 (10) : 1385 - 1385
  • [13] 2-chlorodeoxyadenosine (2-CdA) in the treatment of patients with B-cell chronic lymphocytic leukemia (B-CLL) aged 70 years and older.
    Robak, T
    Blasinska-Morawiec, M
    Blonski, JZ
    [J]. BLOOD, 1998, 92 (10) : 282B - 282B
  • [14] 2-CHLORODEOXYADENOSINE (CDA) THERAPY IN ADVANCED CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) AND IN WALDENSTROMS MACROGLOBULINEMIA (WM)
    DELANNOY, A
    FERRANT, A
    MARTIAT, P
    MONTFORT, L
    DOYEN, C
    SOKAL, G
    MICHAUX, JL
    [J]. BLOOD, 1993, 82 (10) : A562 - A562
  • [15] A phase II study of sequential combination chemotherapy with cyclophosphamide (CTX), prednisone, and 2-chlorodeoxyadenosine (2-CDA) in previously untreated patients with chronic lymphocytic leukemia (CLL).
    Tefferi, A
    Reeder, CB
    Geyer, SM
    Allmer, C
    Li, CY
    Levitt, R
    Michalak, JC
    Addo, F
    Krook, JE
    Witzig, TE
    Schaefer, PL
    Maillard, JA
    [J]. BLOOD, 2000, 96 (11) : 296B - 296B
  • [16] 2-chlorodeoxyadenosine (2-CDA) does not change the expression of Fas antigen on chronic lymphocytic leukaemia cells
    Gora-Tybor, J
    Lech-Maranda, E
    Blonski, JZ
    Robak, T
    [J]. PURINE AND PYRIMIDINE METABOLISM IN MAN X, 2000, 486 : 307 - 310
  • [17] 2-CHLORODEOXYADENOSINE (2-CDA) - A POTENT CHEMOTHERAPEUTIC AND IMMUNOSUPPRESSIVE NUCLEOSIDE
    BEUTLER, E
    PIRO, L
    SAVEN, A
    KAY, AC
    MCMILLAN, R
    LONGMIRE, R
    CARRERA, CJ
    MORIN, P
    CARSON, DA
    [J]. LEUKEMIA & LYMPHOMA, 1991, 5 (01) : 1 - 8
  • [18] 2-chlorodeoxyadenosine (2-CdA) in patients with lupus nephritis.
    HearthHolmes, M
    Holcombe, RF
    Elder, C
    Wolf, RE
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1359 - 1359
  • [19] Sequential treatment of chronic lymphocytic leukemia (CLL) with Bryostatin I and 2-chlorodeoxyadenosine: A preclinical study
    Katato, K
    Mohammad, RM
    Dugan, MC
    Saleh, M
    Ahmad, I
    Almatchy, VP
    Varterasian, ML
    AlKatib, A
    [J]. BLOOD, 1996, 88 (10) : 2349 - 2349
  • [20] 2-CHLORODEOXYADENOSINE TREATMENT OF REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA
    SAVEN, A
    CARRERA, CJ
    CARSON, DA
    BEUTLER, E
    PIRO, LD
    [J]. LEUKEMIA & LYMPHOMA, 1991, 5 : 133 - 138
12345